Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
Briopryme Biologics, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $400,000 in 2023. These are non-dilutive federal research grants, not equity financing. The company is based in Folsom, California.
1 round · latest STTR Phase I award (HHS), Jun 2023
Sign in to see 1 rounds.
Sign inNo investors recorded yet for Briopryme Biologics, Inc..
Add an investorBriopryme Biologics, Inc. has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Briopryme Biologics, Inc..
Add diversity data